BioNexus Gene Lab Corp Common stock (BGLC) — Cash Flow Quality Index
BioNexus Gene Lab Corp Common stock (BGLC) has a Cash Flow Quality Index of -3.38x as of June 2024. Operating cash flow of $-672.27K is below net income of $199.10K, suggesting accrual-heavy earnings not yet converted to cash. Explore BGLC long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioNexus Gene Lab Corp Common stock Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for BioNexus Gene Lab Corp Common stock across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BGLC goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BioNexus Gene Lab Corp Common stock (2018–2021)
Year-by-year earnings quality comparison for BioNexus Gene Lab Corp Common stock. For live market cap and the full company financial profile, see BGLC market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | $9.16K | $751.57K | ▼ -97.6% |
| 2020 | 0.51x | $552.68K | $1.09 Million | ▲ +104.9% |
| 2018 | -10.36x | $-274.08K | $26.45K | — |